Jennison Associates LLC Buys 21,089 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Jennison Associates LLC boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 493,363 shares of the company's stock after purchasing an additional 21,089 shares during the period. Jennison Associates LLC owned about 0.29% of Option Care Health worth $11,446,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Wellington Management Group LLP raised its stake in shares of Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after purchasing an additional 1,328,326 shares during the period. FMR LLC raised its position in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP boosted its stake in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after acquiring an additional 599,589 shares during the last quarter. State Street Corp increased its stake in shares of Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company's stock worth $195,849,000 after purchasing an additional 83,395 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its holdings in shares of Option Care Health by 7.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock worth $183,541,000 after purchasing an additional 404,811 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Price Performance

NASDAQ:OPCH traded up $0.16 during mid-day trading on Friday, hitting $30.98. 940,840 shares of the stock traded hands, compared to its average volume of 1,963,724. The business's 50-day moving average price is $26.04 and its 200 day moving average price is $27.90. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market cap of $5.27 billion, a PE ratio of 26.03, a price-to-earnings-growth ratio of 2.19 and a beta of 1.35. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63.

Wall Street Analyst Weigh In

OPCH has been the subject of several research reports. Barrington Research increased their price objective on Option Care Health from $32.00 to $33.00 and gave the company an "outperform" rating in a report on Tuesday, January 14th. JPMorgan Chase & Co. increased their price target on Option Care Health from $38.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $32.25.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.